Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000413270 | SCV000491884 | uncertain significance | not specified | 2016-11-16 | criteria provided, single submitter | clinical testing | The N364H variant in the FAN1 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The N364H variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The N364H variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is not conserved. In silico analysis predicts this variant likely does not alter the protein structure/function. We interpret N364H as a variant of uncertain significance. |
Fulgent Genetics, |
RCV000763956 | SCV000894903 | uncertain significance | Karyomegalic interstitial nephritis | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000880502 | SCV001023599 | benign | not provided | 2023-04-09 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003970093 | SCV004781879 | likely benign | FAN1-related disorder | 2022-03-21 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |